Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-May-24 11:57 AM View:  | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 23-May-24 | Grant | 2,000,000 | -- | -- | 44% 4.5M to 6.5M | |
| 28-May-24 11:58 AM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 23-May-24 | Grant | 1,000,000 | -- | -- | 16% 6.19M to 7.19M | |
| 02-Nov-23 4:02 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 31-Oct-23 | Grant | 250,000 | -- | -- | 6% 4.25M to 4.5M | |
| 02-Nov-23 4:02 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 31-Oct-23 | Grant | 250,000 | -- | -- | 4% 5.94M to 6.19M | |
| 03-Aug-23 10:23 AM View: | Goldfarb Robert I Chief Operating Officer | Nexien Biopharma, Inc. (NXEN) | 25-Jul-23 | Grant | 250,000 | -- | -- | 12% 2.03M to 2.28M | |
| 31-Jul-23 5:41 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 25-Jul-23 | Grant | 250,000 | -- | -- | 4% 5.69M to 5.94M | |
| 31-Jul-23 3:35 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 25-Jul-23 | Grant | 250,000 | -- | -- | 6% 4.0M to 4.25M | |
| 19-Apr-23 6:48 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 01-Apr-23 | Grant | 250,000 | -- | -- | 7% 3.75M to 4.0M | |
| 03-Aug-23 10:23 AM View: | Goldfarb Robert I Chief Operating Officer | Nexien Biopharma, Inc. (NXEN) | 01-Apr-23 | Grant | 250,000 | -- | -- | 14% 1.78M to 2.03M | |
| 19-Apr-23 4:16 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 01-Apr-23 | Grant | 250,000 | -- | -- | 5% 5.44M to 5.69M | |
| 17-Jan-23 1:23 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 17-Jan-23 | Grant | 250,000 | -- | -- | 7% 3.5M to 3.75M | |
| 18-Jan-23 5:42 PM View: | Goldfarb Robert I Chief Operating Officer | Nexien Biopharma, Inc. (NXEN) | 17-Jan-23 | Grant | 250,000 | -- | -- | 16% 1.53M to 1.78M | |
| 17-Jan-23 1:27 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 17-Jan-23 | Grant | 250,000 | -- | -- | 5% 5.19M to 5.44M | |
| 18-Oct-22 11:07 AM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 17-Oct-22 | Grant | 250,000 | -- | -- | 5% 4.94M to 5.19M | |
| 18-Oct-22 11:04 AM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 17-Oct-22 | Grant | 250,000 | -- | -- | 8% 3.25M to 3.5M | |
| 18-Oct-22 12:45 PM View: | Goldfarb Robert I Chief Operating Officer | Nexien Biopharma, Inc. (NXEN) | 17-Oct-22 | Grant | 250,000 | -- | -- | 20% 1.28M to 1.53M | |
| 14-Sep-22 5:42 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 27-Jul-22 | Grant | 250,000 | -- | -- | 8% 3.0M to 3.25M | |
| 14-Sep-22 5:45 PM View: | Goldfarb Robert I Chief Operating Officer | Nexien Biopharma, Inc. (NXEN) | 27-Jul-22 | Grant | 250,000 | -- | -- | 24% 1.03M to 1.28M | |
| 15-Sep-22 4:06 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 27-Jul-22 | Grant | 250,000 | -- | -- | 5% 4.69M to 4.94M | |
| 15-Sep-22 4:06 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 20-Apr-22 | Grant | 250,000 | -- | -- | 6% 4.44M to 4.69M | |
| 14-Sep-22 5:42 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 20-Apr-22 | Grant | 250,000 | -- | -- | 9% 2.75M to 3.0M | |
| 31-Jan-22 3:56 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 27-Jan-22 | Grant | 250,000 | -- | -- | 6% 4.19M to 4.44M | |
| 31-Jan-22 3:55 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 27-Jan-22 | Grant | 250,000 | -- | -- | 10% 2.5M to 2.75M | |
| 29-Nov-21 12:20 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 29-Nov-21 | Grant | 500,000 | -- | -- | (17%) 3.0M to 2.5M | |
| 29-Nov-21 12:23 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 29-Nov-21 | Grant | 500,000 | -- | -- | 14% 3.69M to 4.19M | |
| 07-Jun-21 6:00 PM View: | Snider Lindy Director | Nexien Biopharma, Inc. (NXEN) | 07-Jun-21 | Grant | 250,000 | -- | -- | 52% 480.0K to 730.0K | |
| 05-Apr-21 5:33 PM View: | Greenberg Richard S Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 01-Apr-21 | Grant | 1,000,000 | -- | -- | 37% 2.69M to 3.69M | |
| 05-Apr-21 5:34 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 01-Apr-21 | Grant | 1,000,000 | -- | -- | 100% 1000.0K to 2.0M | |
| 14-Aug-20 5:33 PM View: | Greenberg Richard S Chief Executive Officer Director | Nexien Biopharma, Inc. (NXEN) | 12-Aug-20 | Conversion | 1,800,880 | $0.01 | $25,212.30 | 203% 888.0K to 2.69M | |
| 25-Nov-19 2:07 PM View: | Friedland Jeffrey | Nexien Biopharma, Inc. (NXEN) | 22-Nov-19 | Gift | 833,333 | -- | -- | (4%) 20.06M to 19.23M | |
| 25-Nov-19 2:07 PM View: | Friedland Jeffrey | Nexien Biopharma, Inc. (NXEN) | 22-Nov-19 | Gift | 228,800 | -- | -- | (1%) 19.23M to 19.0M | |
| 01-May-19 7:56 PM View: | Friedland Jeffrey | Nexien Biopharma, Inc. (NXEN) | 04-Apr-19 | Sale Duplicate | 5,000,000 | $0.09 | $425,000.00 | (20%) 25.06M to 20.06M | |
| 01-May-19 7:15 PM View: | Intiva Usa Inc 10% Owner | Nexien Biopharma, Inc. (NXEN) | 04-Apr-19 | Sale | 5,000,000 | $0.09 | $425,000.00 | (21%) 24.0M to 19.0M | |
| 02-May-19 2:08 PM View: | Kanativa Inc. 10% Owner | Nexien Biopharma, Inc. (NXEN) | 04-Apr-19 | Sale Duplicate | 5,000,000 | $0.09 | $425,000.00 | (21%) 24.0M to 19.0M | |
| 29-Jun-18 12:43 PM View: | Greenberg Richard S EVP and Chairman Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 28-Jun-18 | Exercise (in-the money or at-the-money) | 88,000 | $0.38 | $33,440.00 | < 1% 24.8M to 24.89M | |
| 29-Jun-18 12:14 PM View: | Snider Lindy Director | Nexien Biopharma, Inc. (NXEN) | 19-Jun-18 | Exercise (in-the money or at-the-money) | 40,000 | $0.38 | $15,200.00 | 9% 440.0K to 480.0K | |
| 23-May-18 10:51 AM View: | Bankier Alain D Chief Executive Officer Director | Nexien Biopharma, Inc. (NXEN) | 15-May-18 | Exercise (in-the money or at-the-money) | 28,000 | $0.38 | $10,640.00 | 1% 2.23M to 2.26M | |
| 22-May-18 5:30 PM View: | Goldfarb Robert I Chief Operating Officer | Nexien Biopharma, Inc. (NXEN) | 05-May-18 | Exercise (in-the money or at-the-money) | 2,400 | $0.38 | $912.00 | < 1% 1.03M to 1.03M | |
| 12-Mar-18 7:13 PM View: | Friedland Jeffrey | Nexien Biopharma, Inc. (NXEN) | 08-Mar-18 | Disposition | 1,166,670 | -- | -- | (4%) 26.23M to 25.06M | |
| 23-Feb-18 3:31 PM View: | Friedland Jeffrey Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 16-Jan-18 | Acquisition (small) | 20,800 | $0.25 | $5,200.00 | < 1% 26.21M to 26.23M | |
| 26-Feb-18 1:10 PM View: | Bankier Alain D Director | Nexien Biopharma, Inc. (NXEN) | 12-Jan-18 | Acquisition (small) | 28,000 | $0.25 | $7,000.00 | 1% 2.2M to 2.23M | |
| 26-Feb-18 2:53 PM View: | Goldfarb Robert I Chief Operating Officer | Nexien Biopharma, Inc. (NXEN) | 12-Jan-18 | Acquisition (small) | 2,400 | $0.25 | $600.00 | < 1% 1.02M to 1.03M | |
| 30-Nov-17 2:54 PM View: | Friedland Jeffrey Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 29-Nov-17 | Acquisition (other) | 130,859 | -- | -- | < 1% 26.08M to 26.21M | |
| 30-Nov-17 6:40 PM View: | Greenberg Richard S EVP and Chairman Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 29-Nov-17 | Acquisition (other) | 503,303 | -- | -- | 2% 24.3M to 24.8M | |
| 30-Nov-17 2:55 PM View: | Intiva Usa Inc 10% Owner | Nexien Biopharma, Inc. (NXEN) | 29-Nov-17 | Acquisition (other) | 15,099,100 | -- | -- | 170% 8.9M to 24.0M | |
| 01-Dec-17 10:37 AM View: | Goldfarb Robert I Chief Operating Officer | Nexien Biopharma, Inc. (NXEN) | 29-Nov-17 | Acquisition (other) | 644,227 | -- | -- | 170% 379.77K to 1.02M | |
| 30-Nov-17 2:54 PM View: | Friedland Jeffrey Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 29-Nov-17 | Acquisition (other) Duplicate | 15,099,100 | -- | -- | 155% 9.72M to 24.82M | |
| 30-Nov-17 2:54 PM View: | Friedland Jeffrey Chief Executive Officer Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 29-Nov-17 | Acquisition (other) | 1,258,260 | -- | -- | 5% 24.82M to 26.08M | |
| 30-Nov-17 1:08 PM View: | Wasoff Evan L Chief Financial Officer | Nexien Biopharma, Inc. (NXEN) | 29-Nov-17 | Acquisition (other) | 629,128 | -- | -- | 170% 370.87K to 1000.0K | |
| 30-Nov-17 6:40 PM View: | Greenberg Richard S EVP and Chairman Director 10% Owner | Nexien Biopharma, Inc. (NXEN) | 29-Nov-17 | Acquisition (other) Duplicate | 15,099,100 | -- | -- | 164% 9.2M to 24.3M |
